Commentary to “Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials” (Galvano et al. J Bone Oncol 2019; 18:100252)

Detalles Bibliográficos
Autores principales: Gonzalez-Rodriguez, Elena, Aubry-Rozier, Bérengère, Stoll, Delphine, Zaman, Khalil, Lamy, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385537/
https://www.ncbi.nlm.nih.gov/pubmed/32742916
http://dx.doi.org/10.1016/j.jbo.2020.100294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385537/
https://www.ncbi.nlm.nih.gov/pubmed/32742916
http://dx.doi.org/10.1016/j.jbo.2020.100294

Ejemplares similares